Villarta, Roy O.
HRN: 13-75-69 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/04/2025
CEFUROXIME 750MG (VIAL)
12/04/2025
12/17/2025
IV
750mg
Q8
Galeazzi Fracture
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes